Relay Therapeutics Company
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Investors
Headquarters:
Cambridge, Massachusetts, United States
Industry:
End-to-End Drug Development
Employee Number:
101-250
Estimated Revenue:
$1M to $10M
Investors Number:
12.0
Funding Status:
IPO
Acquisitions Number:
1
Technology:
Biotechnology, Health Care, Therapeutics
Last Funding Type:
Post-IPO Equity
Founded Date:
2016-01-01
Total Funding:
1170000000.0
Last Funding Date:
2022-09-12